This bill seeks to amend various provisions related to the sale and regulation of cannabis, particularly focusing on hemp-derived cannabinoids and medical cannabis. It shifts oversight responsibilities from the "commissioner" to the "office," clarifying the definition of "health care practitioner" and expanding the office's role in overseeing medical cannabis manufacturers and ensuring compliance with regulations. The bill introduces new reporting requirements, safety criteria for patients, and provisions for the Cannabis Advisory Council to guide the therapeutic use of medical cannabis. Additionally, it addresses limits on delta-9 tetrahydrocannabinol in edible products, repeals certain existing statutes, and enhances the regulatory framework for cannabis management.

Moreover, the bill establishes new licensing categories, including a "lower-potency hemp edible wholesaler," and outlines specific application and renewal fees. It mandates that local governments cannot prohibit cannabis businesses but can impose reasonable operational restrictions. The legislation emphasizes compliance with state and local regulations, including age verification for sales and secure storage for lower-potency hemp edibles. It also introduces packaging and labeling requirements for hemp-derived products, ensuring consumer safety and compliance within the industry. Overall, the bill aims to create a more supportive and regulated environment for cannabis and hemp businesses in Minnesota while protecting the rights and safety of patients and consumers.

Statutes affected:
Introduction: 151.72, 342.01, 342.46
1st Engrossment: 152.22, 152.24, 152.25, 152.26, 152.261, 152.27, 152.28, 152.29, 152.31, 152.32, 152.33, 152.35, 152.37, 342.01, 342.02, 342.09, 342.51, 342.515, 342.52, 342.57, 342.59, 342.12, 342.14, 342.151, 342.17, 342.22, 342.28, 342.29, 342.30, 342.32, 342.33, 342.36, 342.37, 342.43, 342.61, 342.63, 151.72, 342.10, 342.11, 342.13, 342.18, 342.34, 342.39, 342.44, 342.45, 342.46, 342.62, 342.65, 342.66